| __timestamp | Mesoblast Limited | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 55305000 | 15635076 |
| Thursday, January 1, 2015 | 77593000 | 23943601 |
| Friday, January 1, 2016 | 50013000 | 23689111 |
| Sunday, January 1, 2017 | 58914000 | 41006114 |
| Monday, January 1, 2018 | 65927000 | 51379106 |
| Tuesday, January 1, 2019 | 59815000 | 32705593 |
| Wednesday, January 1, 2020 | 56188000 | 53274000 |
| Friday, January 1, 2021 | 53012000 | 85352000 |
| Saturday, January 1, 2022 | 32815000 | 51999000 |
| Sunday, January 1, 2023 | 27189000 | 59471000 |
| Monday, January 1, 2024 | 25353000 |
Unleashing insights
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Summit Therapeutics Inc. and Mesoblast Limited have been at the forefront of this race. From 2014 to 2023, Mesoblast consistently invested heavily in R&D, peaking in 2015 with a 40% increase from the previous year. However, their spending saw a gradual decline, dropping by nearly 50% by 2023. In contrast, Summit Therapeutics displayed a more volatile pattern, with a significant surge in 2021, marking a 60% increase from 2020. This trend highlights Summit's aggressive push towards innovation, even as Mesoblast's spending waned. The data for 2024 remains incomplete, leaving room for speculation on future strategies. As these companies navigate the challenges of the biotech industry, their R&D investments will continue to shape their competitive edge.
Analyzing R&D Budgets: Vertex Pharmaceuticals Incorporated vs Mesoblast Limited
R&D Insights: How Takeda Pharmaceutical Company Limited and Mesoblast Limited Allocate Funds
Research and Development: Comparing Key Metrics for BeiGene, Ltd. and Summit Therapeutics Inc.
Research and Development Expenses Breakdown: Neurocrine Biosciences, Inc. vs Summit Therapeutics Inc.
Summit Therapeutics Inc. or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Summit Therapeutics Inc. or ACADIA Pharmaceuticals Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Summit Therapeutics Inc. vs ImmunityBio, Inc.
Research and Development Investment: Summit Therapeutics Inc. vs Soleno Therapeutics, Inc.
R&D Insights: How Corcept Therapeutics Incorporated and Mesoblast Limited Allocate Funds
Research and Development: Comparing Key Metrics for Xenon Pharmaceuticals Inc. and Mesoblast Limited
R&D Insights: How Mesoblast Limited and Wave Life Sciences Ltd. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Mesoblast Limited and Travere Therapeutics, Inc.